An Open-label, Long-term Extension Study to Evaluate the Safety, Tolerability and Efficacy of 12 Months of LCZ696 Treatment in Patients With Essential Hypertension
An Open-label, Long-term Extension Study to Evaluate the Safety, Tolerability and Efficacy of 12 Months of LCZ696 Treatment in Patients With Essential Hypertension
The purpose of this study is to assess the long-term safety, tolerability and efficacy of LCZ696.
Inclusion Criteria:
Exclusion Criteria:
Bunkyo-ku, Tokyo 113-0031, Japan
Chiyoda-ku, Tokyo 100-0005, Japan
Minato-ku, Tokyo 105-7390, Japan
Minato-ku, Tokyo 108-0075, Japan
Shinagawa-ku, Tokyo 141-0032, Japan
Shinagawa-ku, Tokyo 142-0053, Japan
Shinagawa-ku, Tokyo 142-0063, Japan
Toshima-ku, Tokyo 171-0021, Japan
Koyang, Kyunggi 410-719, South Korea